Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2022 Volume 26 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2022 Volume 26 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury in vitro by targeting PDCD6IP

  • Authors:
    • Yihan Wang
    • Jiahui Jin
    • Zongxin Xia
    • Huisheng Chen
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110013, P.R. China, Department of Neurology, Jilin City Central Hospital, Jilin, Jilin 132011, P.R. China, Department of Neurology, Baishan City Central Hospital, Baishan, Jilin 134399, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 322
    |
    Published online on: August 31, 2022
       https://doi.org/10.3892/mmr.2022.12838
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The purpose of the present study was to explore the functional role of microRNA (miR)‑363‑3p and related regulatory mechanisms in cerebral ischemia/reperfusion (I/R) injury. The neuronal cell line SH‑SY5Y was exposed to 4 h of oxygen and glucose deprivation (OGD), followed by 6, 12, 24 and 48 h of re‑oxygenation to mimic I/R injury in vitro. Cell viability, apoptosis and inflammation were assessed by CCK‑8, lactate dehydrogenase (LDH), flow cytometry and ELISA assays. The association between miR‑363‑3p and programmed cell death 6‑interacting protein (PDCD6IP) was further confirmed using luciferase reporter assay. Our data revealed that the expression level of miR‑363‑3p was significantly downregulated after OGD/R induction. Overexpression of miR‑363‑3p markedly suppressed OGD/R‑induced cell injury, as reflected by attenuated cell viability, reduced apoptosis, LDH activity and pro‑inflammatory cytokine levels. Mechanistically, PDCD6IP was confirmed as the target of miR‑363‑3p. Furthermore, PDCD6IP knockdown imitated, while overexpression reversed the effects of miR‑363‑3p overexpression on OGD/R‑induced cell injury. Collectively, miR‑363‑3p could attenuate OGD/R‑induced cell injury by alleviating apoptosis and inflammation, which may be mediated, at least in part, via inhibition of PDCD6IP.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Chugh C: Acute ischemic stroke: Management approach. Indian J Crit Care Med. 23 (Suppl 2):S140–S146. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Xu F, Ma R, Zhang G, Wang S, Yin J, Wang E, Xiong E, Zhang Q and Li Y: Estrogen and propofol combination therapy inhibits endoplasmic reticulum stress and remarkably attenuates cerebral ischemia-reperfusion injury and OGD injury in hippocampus. Biomed Pharmacother. 108:1596–1606. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Yan RY, Wang SJ, Yao GT, Liu ZG and Xiao N: The protective effect and its mechanism of 3-n-butylphthalide pretreatment on cerebral ischemia reperfusion injury in rats. Eur Rev Med Pharmacol Sci. 21:5275–5282. 2017.PubMed/NCBI

4 

Tuttolomondo A, Di Sciacca R, Di Raimondo D, Renda C, Pinto A and Licata G: Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem. 9:1240–1260. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Ornellas FM, Ornellas DS, Martini SV, Castiglione RC, Ventura GM, Rocco PR, Gutfilen B, de Souza SA, Takiya CM and Morales MM: Bone marrow-derived mononuclear cell therapy accelerates renal ischemia-reperfusion injury recovery by modulating inflammatory, antioxidant and apoptotic related molecules. Cell Physiol Biochem. 41:1736–1752. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Yingjie K, Haihong Y, Lingwei C, Sen Z, Yuanting D, Shasha C, Liutong P, Ying W and Min Z: Apoptosis repressor with caspase recruitment domain deficiency accelerates ischemia/reperfusion (I/R)-induced acute kidney injury by suppressing inflammation and apoptosis: The role of AKT/mTOR signaling. Biomed Pharmacother. 112:1086812019. View Article : Google Scholar : PubMed/NCBI

7 

Lv Z, Liu C, Zhai M, Zhang Q, Li J, Zheng F and Peng M: LPS pretreatment attenuates cerebral ischaemia/reperfusion injury by inhibiting inflammation and apoptosis. Cell Physiol Biochem. 45:2246–2256. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Rippe C, Blimline M, Magerko KA, Lawson BR, LaRocca TJ, Donato AJ and Seals DR: MicroRNA changes in human arterial endothelial cells with senescence: Relation to apoptosis, eNOS and inflammation. Exp Gerontol. 47:45–51. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH and Rehimi H: The role of miRNA in inflammation and autoimmunity. Autoimmun Rev. 12:1160–1165. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Ferrante M and Conti GO: Environment and neurodegenerative diseases: An update on miRNA role. Microrna. 6:157–165. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Wang R, Bao H, Zhang S, Li R, Chen L and Zhu Y: miR-186-5p promotes apoptosis by targeting IGF-1 in SH-SY5Y OGD/R model. Int J Biol Sci. 14:1791–1799. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Ren X, Wang Z and Guo C: MiR-195-5p ameliorates cerebral ischemia-reperfusion injury by regulating the PTEN-AKT signaling pathway. Neuropsychiatr Dis Treat. 17:1231–1242. 2021. View Article : Google Scholar : PubMed/NCBI

14 

Wu Y, Yao J and Feng K: miR-124-5p/NOX2 axis modulates the ROS production and the inflammatory microenvironment to protect against the cerebral I/R injury. Neurochem Res. 45:404–417. 2020. View Article : Google Scholar : PubMed/NCBI

15 

Sohrabji F and Selvamani A: Sex differences in miRNA as therapies for ischemic stroke. Neurochem Int. 127:56–63. 2019. View Article : Google Scholar : PubMed/NCBI

16 

Selvamani A and Sohrabji F: Mir363-3p improves ischemic stroke outcomes in female but not male rats. Neurochem Int. 107:168–181. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Wang K, Yan L and Lu F: miR-363-3p inhibits osteosarcoma cell proliferation and invasion via targeting SOX4. Oncol Res. 27:157–163. 2019. View Article : Google Scholar : PubMed/NCBI

18 

Chen J, Lai W, Deng Y, Liu M, Dong M, Liu Z, Wang T, Li X, Zhao Z, Yin X, et al: MicroRNA-363-3p promotes apoptosis in response to cadmium-induced renal injury by down-regulating phosphoinositide 3-kinase expression. Toxicol Lett. 345:12–23. 2021. View Article : Google Scholar : PubMed/NCBI

19 

Zhou T, Li S, Yang L and Xiang D: microRNA-363-3p reduces endothelial cell inflammatory responses in coronary heart disease via inactivation of the NOX4-dependent p38 MAPK axis. Aging (Albany NY). 13:11061–11082. 2021. View Article : Google Scholar : PubMed/NCBI

20 

Missotten M, Nichols A, Rieger K and Sadoul R: Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 6:124–129. 1999. View Article : Google Scholar : PubMed/NCBI

21 

Hashemi M, Yousefi J, Hashemi SM, Amininia S, Ebrahimi M, Taheri M and Ghavami S: Association between programmed cell death 6 interacting protein insertion/deletion polymorphism and the risk of breast cancer in a sample of Iranian population. Dis Markers. 2015:8546212015. View Article : Google Scholar : PubMed/NCBI

22 

Ajasin DO, Rao VR, Wu X, Ramasamy S, Pujato M, Ruiz AP, Fiser A, Bresnick AR, Kalpana GV and Prasad VR: CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release. Elife. 8:e355462019. View Article : Google Scholar : PubMed/NCBI

23 

Xu C, Sun G, Yang J, Sun Q and Tong Z: Interleukin-13 promotes expression of Alix to compromise renal tubular epithelial barrier function. Cell Biol Int. 39:548–553. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Wu B, Liu J, Zhao R, Li Y, Peer J, Braun AL, Zhao L, Wang Y, Tong Z, Huang Y and Zheng JC: Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate. J Neuroinflammation. 15:792018. View Article : Google Scholar : PubMed/NCBI

25 

Li J, Yang C and Wang Y: miR-126 overexpression attenuates oxygen-glucose deprivation/reperfusion injury by inhibiting oxidative stress and inflammatory response via the activation of SIRT1/Nrf2 signaling pathway in human umbilical vein endothelial cells. Mol Med Rep. 23:1652021. View Article : Google Scholar : PubMed/NCBI

26 

Zhang L, Cai Q, Lin S, Chen B, Jia B, Ye R, Weygant N, Chu J and Peng J: Qingda granule exerts neuroprotective effects against ischemia/reperfusion-induced cerebral injury via lncRNA GAS5/miR-137 signaling pathway. Int J Med Sci. 18:1687–1698. 2021. View Article : Google Scholar : PubMed/NCBI

27 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Rong H, Chen B, Wei X, Peng J, Ma K, Duan S and He J: Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p. Thorac Cancer. 11:659–671. 2020. View Article : Google Scholar : PubMed/NCBI

29 

Zhang JF, Zhang L, Shi LL, Zhao ZH, Xu H, Liang F, Li HB, Zhao Y, Xu X, Yang K and Tian YF: Parthenolide attenuates cerebral ischemia/reperfusion injury via Akt/GSK-3β pathway in PC12 cells. Biomed Pharmacother. 89:1159–1165. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Tian M, Yang M, Li Z, Wang Y, Chen W, Yang L, Li Y and Yuan H: Fluoxetine suppresses inflammatory reaction in microglia under OGD/R challenge via modulation of NF-κB signaling. Biosci Rep. 39:BSR201815842019. View Article : Google Scholar : PubMed/NCBI

31 

Chatellard-Causse C, Blot B, Cristina N, Torch S, Missotten M and Sadoul R: Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization. J Biol Chem. 277:29108–29115. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Schaller B and Graf R: Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab. 24:351–371. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Vasudeva K and Munshi A: miRNA dysregulation in ischaemic stroke: Focus on diagnosis, prognosis, therapeutic and protective biomarkers. Eur J Neurosci. 52:3610–3627. 2020. View Article : Google Scholar : PubMed/NCBI

34 

Xu S, Li Y, Chen JP, Li DZ, Jiang Q, Wu T and Zhou XZ: Oxygen glucose deprivation/re-oxygenation-induced neuronal cell death is associated with Lnc-D63785 m6A methylation and miR-422a accumulation. Cell Death Dis. 11:8162020. View Article : Google Scholar : PubMed/NCBI

35 

Chai Z, Gong J, Zheng P and Zheng J: Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro. Biol Res. 53:172020. View Article : Google Scholar : PubMed/NCBI

36 

Liu Y, Eaton ED, Wills TE, McCann SK, Antonic A and Howells DW: Human ischaemic cascade studies using SH-SY5Y cells: A systematic review and meta-analysis. Transl Stroke Res. 9:564–574. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Xiang Y, Zhang Y, Xia Y, Zhao H, Liu A and Chen Y: LncRNA MEG3 targeting miR-424-5p via MAPK signaling pathway mediates neuronal apoptosis in ischemic stroke. Aging (Albany NY). 12:3156–3174. 2020. View Article : Google Scholar : PubMed/NCBI

38 

Dong J, Geng J and Tan W: MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2. Biomed Pharmacother. 105:922–931. 2018. View Article : Google Scholar : PubMed/NCBI

39 

Chang J, Gao F, Chu H, Lou L, Wang H and Chen Y: miR-363-3p inhibits migration, invasion, and epithelial-mesenchymal transition by targeting NEDD9 and SOX4 in non-small-cell lung cancer. J Cell Physiol. 235:1808–1820. 2020. View Article : Google Scholar : PubMed/NCBI

40 

Ma X, Jin L, Lei X, Tong J and Wang R: MicroRNA-363-3p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA. Oncol Rep. 43:1365–1374. 2020.PubMed/NCBI

41 

Zhu L, Zhang L, Tang Y, Zhang F, Wan C, Xu L and Guo P: MicroRNA-363-3p inhibits tumor cell proliferation and invasion in oral squamous cell carcinoma cell lines by targeting SSFA2. Exp Ther Med. 21:5492021. View Article : Google Scholar : PubMed/NCBI

42 

Chen Y, Chen S, Lu J, Yuan D, He L, Qin P, Tan H and Xu L: MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B. Medicine (Baltimore). 100:e258072021. View Article : Google Scholar : PubMed/NCBI

43 

Dong X, Li Y, Cao R and Xu H: MicroRNA-363-3p inhibits the expression of renal fibrosis markers in TGF-β1-treated HK-2 cells by targeting TGF-β2. Biochem Genet. 59:1033–1048. 2021. View Article : Google Scholar : PubMed/NCBI

44 

Dirnagl U, Iadecola C and Moskowitz MA: Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 22:391–397. 1999. View Article : Google Scholar : PubMed/NCBI

45 

Chamorro Á, Dirnagl U, Urra X and Planas AM: Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 15:869–881. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Zhang M, Wang Z, Li B, Sun F, Chen A and Gong M: Identification of microRNA-363-3p as an essential regulator of chondrocyte apoptosis in osteoarthritis by targeting NRF1 through the p53-signaling pathway. Mol Med Rep. 21:1077–1088. 2020.PubMed/NCBI

47 

Gao C, Qian H, Shi Q and Zhang H: MicroRNA-363-3p serves as a diagnostic biomarker of acute myocardial infarction and regulates vascular endothelial injury by targeting KLF2. Cardiovasc Diagn Ther. 10:421–430. 2020. View Article : Google Scholar : PubMed/NCBI

48 

Hemming FJ, Fraboulet S, Blot B and Sadoul R: Early increase of apoptosis-linked gene-2 interacting protein X in areas of kainate-induced neurodegeneration. Neuroscience. 123:887–895. 2004. View Article : Google Scholar : PubMed/NCBI

49 

Blum D, Hemming FJ, Galas MC, Torch S, Cuvelier L, Schiffmann SN and Sadoul R: Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid. Neurosci Lett. 368:309–313. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang Y, Jin J, Xia Z and Chen H: miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP. Mol Med Rep 26: 322, 2022.
APA
Wang, Y., Jin, J., Xia, Z., & Chen, H. (2022). miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP. Molecular Medicine Reports, 26, 322. https://doi.org/10.3892/mmr.2022.12838
MLA
Wang, Y., Jin, J., Xia, Z., Chen, H."miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP". Molecular Medicine Reports 26.5 (2022): 322.
Chicago
Wang, Y., Jin, J., Xia, Z., Chen, H."miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP". Molecular Medicine Reports 26, no. 5 (2022): 322. https://doi.org/10.3892/mmr.2022.12838
Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Jin J, Xia Z and Chen H: miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP. Mol Med Rep 26: 322, 2022.
APA
Wang, Y., Jin, J., Xia, Z., & Chen, H. (2022). miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP. Molecular Medicine Reports, 26, 322. https://doi.org/10.3892/mmr.2022.12838
MLA
Wang, Y., Jin, J., Xia, Z., Chen, H."miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP". Molecular Medicine Reports 26.5 (2022): 322.
Chicago
Wang, Y., Jin, J., Xia, Z., Chen, H."miR‑363‑3p attenuates the oxygen‑glucose deprivation/reoxygenation‑induced neuronal injury <em>in vitro</em> by targeting PDCD6IP". Molecular Medicine Reports 26, no. 5 (2022): 322. https://doi.org/10.3892/mmr.2022.12838
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team